Details

Autor(en) / Beteiligte

• Ross, Colton J.
• Laurence, Devin W.
• Hsu, Ming-Chen
• Baumwart, Ryan
• Zhao, Yan D.
• Mir, Arshid
• Burkhart, Harold M.
• Holzapfel, Gerhard A.
• Wu, Yi
• Lee, Chung-Hao

Titel

Mechanics of Porcine Heart Valves’ Strut Chordae Tendineae Investigated as a Leaflet–Chordae–Papillary Muscle Entity

Ist Teil von

• Annals of biomedical engineering, 2020-05, Vol.48 (5), p.1463-1474

Ort / Verlag

Cham: Springer International Publishing

Erscheinungsjahr

2020

Link zum Volltext

Quelle

Springer

Beschreibungen/Notizen

• Proper blood flow through the atrioventricular heart valves (AHVs) relies on the holistic function of the valve and subvalvular structures, and a failure of any component can lead to life-threatening heart disease. A comprehension of the mechanical characteristics of healthy valvular components is necessary for the refinement of heart valve computational models. In previous studies, the chordae tendineae have been mechanically characterized as individual structures, usually in a clamping-based approach, which may not accurately reflect the in vivo chordal interactions with the leaflet insertion and papillary muscles. In this study, we performed uniaxial mechanical testing of strut chordae tendineae of the AHVs under a unique tine-based leaflet–chordae–papillary muscle testing to observe the chordae mechanics while preserving the subvalvular component interactions. Results of this study provided insight to the disparity of chordae tissue stress-stretch responses between the mitral valve (MV) and the tricuspid valve (TV) under their respective emulated physiological loading. Specifically, strut chordae tendineae of the MV anterior leaflet had peak stretches of 1.09–1.16, while peak stretches of 1.08–1.11 were found for the TV anterior leaflet strut chordae. Constitutive parameters were also derived for the chordae tissue specimens using an Ogden model, which is useful for AHV computational model refinement. Results of this study are beneficial to the eventual improvement of treatment methods for valvular disease.